The Cardiovascular Research Foundation designates this activity for a maximum of 1 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Documentation of awarded credit is provided for participants in exchange for completed activity evaluations. There is no registration fee for this CME activity. If you have previously registered and would like to return to the webcast, please click here.
FACULTY DISCLOSURES
It is the policy of the Cardiovascular Research Foundation to ensure balance, independence, objectivity, and scientific rigor in all of its sponsored educational activities. Commercial support from industry does not influence educational content, faculty selection, and/or faculty presentations, and therefore, does not compromise the scientific integrity of the educational activity.
Discussion of off-label product usage is made at the sole discretion of the faculty. Off-label product discussion and usage is not endorsed by the Cardiovascular Research Foundation or the course directors of this activity.
In accordance with the accredited continuing education sponsored by Cardiovascular Research Foundation (CRF), all planners, teachers, and authors with control over activity content are required to disclose to the provider any relevant financial relationships (those held by the planner, currently or within the last 24 months) with ineligible companies. Accredited providers are required to provide this information to learners before the start of an activity.
Content Reviewer(s):
Gary S. Mintz, MD — Consultant Fee/Honoraria/ Speaker’s Bureau – Boston Scientific Corporation, Abiomed
Grzegorz L. Kaluza, MD, PhD — Grant Support/Research Contract: Abbott Vascular; Abiomed, Medtronic; 4C Medical; Dura Biotech; InQB8; Ancora Heart; InnovHeart; Mitria; Thubrikar Aortic Valve; Terumo Medical Corporation; Bristol-Myers Squibb; Edwards Lifesciences; Alucent Biomedical; Advanced NanoTechnologies; Adriakaim; Thrombolex; Reflow Medical; Tenaya Therapeutics; Renovacor; Shape Memory Medical; Impulse Dynamics; Occlutech; Neochord; MicroInterventional Devices; Lungpacer; Inozyme; HLT; Deinde Medical; Autonomix; Cardiac Implants; Cagent Medical; Intact Vascular; OncoSec; Soundbite Medical Solutions; VasoRx; LivaNova; Encore Medical; Recardia; Cook Medical; StrideBio; Ethicon, a J&J Company.
Donald Cutlip, MD – Nothing to disclose
Anjelica Scaletta-Resias – Nothing to disclose
Thaifa Smith – Nothing to disclose
This program is sponsored by the Cardiovascular Research Foundation and supported through an unrestricted educational grant provided by Edwards Lifesciences.
